Cost-Effectiveness Analysis of Tocilizumab Subcutaneous As First Line Biologic Monotherapy for Rheumatoid Arthritis Management In Greece

Article OPEN
Athanasakis, K; Tarantilis, F; Skroumpelos, A; Kyriopoulos, J;
(2015)
Share - Bookmark